3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
1
Interventions
Trastuzumab
25
Carboplatin
20
Paclitaxel
19
pertuzumab
18
pyrotinib
17
Cyclophosphamide
17
Capecitabine
16
Docetaxel
15
trastuzumab deruxtecan
14
Radiotherapy
13
Drug Therapy
13
Standard of Care
12
Letrozole
12
Fulvestrant
12
dalpiciclib
11
pembrolizumab
9
exemestane
9
Epirubicin
9
Anastrozole
9
sacituzumab govitecan
8
palbociclib
8
eribulin
8
Specimen Handling
8
Doxorubicin
7
130-nm albumin-bound paclitaxel
7
toripalimab
6
abemaciclib
6
Tamoxifen
6
Neoadjuvant Therapy
6
Magnetic Resonance Spectroscopy
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Atropine
×
Breast
×
Clear all
NCT07367178
2026-01-28
SATROPIN
MedSIR
Phase 2
Not yet recruiting
30 enrolled